CARISMA Therapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA, July 30, 2020 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual conferences in August 2020.

LifeSci Partners Private Company Virtual Summer Symposium

Tuesday, August 4, 2020 at 3:30 p.m. EDT

Wedbush PacGrow Healthcare Virtual Conference

Wednesday, August 12, 2020 at 12:35 p.m. EDT

About CARISMA Therapeutics Inc.

CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.

For more information, please visit www.carismatx.com

Christina Khoury-Folkens

SOURCE CARISMA Therapeutics Inc.

more press release views with